rxstat › Shortages › Gadobenate Dimeglumine

Gadobenate Dimeglumine (Multihance) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Nov 3, 2026

Gadobenate Dimeglumine has no current shortage reported in Canada. It has been in shortage before; the history is below.

A contrast agent used to improve the clarity of MRI scans.

Products affected

0 / 1

Reports on file

6

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved

MULTIHANCE

529MG · SOLUTION · BRACCO IMAGING CANADA

DIN 02248302 · ended Oct 3, 2025

Resolved

MULTIHANCE

529MG · SOLUTION · BRACCO IMAGING CANADA

DIN 02248302 · ended Sep 29, 2026

Resolved

MULTIHANCE

529MG · SOLUTION · BRACCO IMAGING CANADA

DIN 02248302 · ended Sep 29, 2026

Resolved

MULTIHANCE

529MG · SOLUTION · BRACCO IMAGING CANADA

DIN 02248302 · ended Aug 8, 2025 · This MultiHance format has been received, released and shipped to Canadian customers

Resolved

MULTIHANCE

529MG · SOLUTION · BRACCO IMAGING CANADA

DIN 02248302 · ended Aug 8, 2025 · This MultiHance format has been received, released and shipped to Canadian customers

Resolved

MULTIHANCE

529MG · SOLUTION · BRACCO IMAGING CANADA

DIN 02248302 · ended Feb 14, 2025 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Gadobenate Dimeglumine. Health Canada has 6 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Gadobenate Dimeglumine is classified under “MAGNETIC RESONANCE IMAGING CONTRAST MEDIA” (ATC V08CA).

Recent changes

Nov 3, 2026 Shortage resolved
Oct 27, 2026 Shortage resolved
Oct 27, 2026 Shortage resolved
Sep 25, 2026 Estimated end date pushed back : Sep 25, 2026 → Sep 28, 2026
Sep 25, 2026 Estimated end date pushed back : Sep 25, 2026 → Sep 28, 2026
Sep 21, 2026 Estimated end date pushed back : Sep 18, 2026 → Sep 25, 2026
Sep 21, 2026 Status changed
Sep 21, 2026 Estimated end date pushed back : Sep 21, 2026 → Sep 25, 2026
Sep 10, 2026 Status changed
Sep 10, 2026 Estimated end date pushed back : Sep 7, 2026 → Sep 18, 2026
Aug 19, 2026 New report filed
Aug 19, 2026 New report filed

Common questions

What is Gadobenate Dimeglumine used for?

A contrast agent used to improve the clarity of MRI scans.

When will Gadobenate Dimeglumine be back in stock in Canada?

Gadobenate Dimeglumine has no active shortage; supply is normal per Health Canada reports.

Why is Gadobenate Dimeglumine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (magnetic resonance imaging contrast media)

Gadodiamide (Omniscan) Discontinued 0 of 1 reported products affected Gadoversetamide (Optimark) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.